Infectious Diseases

Study of C. difficile toxins may lead to new therapies

U.S. researchers have discovered how cells in the gut neutralize toxins produced by Clostridium difficile (C. difficile), a finding that may eventually lead to new methods of treatment.
Incivek: second protease inhibitor approved for chronic hepatitis C

Drug’s marketing date in Canada has not yet been announced.
European agency limits H1N1 vaccine use in kids

Canadian study may shed more light on suspected link with narcolepsy
Sepsis education doesn’t translate into optimal care

Emergency physicians doubt guidelines will save lives
Victrelis for chronic hepatitis C launched

Drug is used in combination with peginterferon alpha/ribavirin.
Fever in returning traveller: new CATMAT guidelines

Fever in a returning international traveller should initially be considered a medical emergency, say guidelines.
The Birds and the Bees and STIs

Preventing and managing common sexually transmitted infections.
Scientists discover first gonorrhea strain resistant to all antibiotics

Strain poses potential threat to public health worldwide, infectious disease experts say.

Adrenal dysfunction seen in babies exposed to moms' protease inhibitors